Results 271 to 280 of about 185,125 (388)

Cost-effectiveness of proton-pump inhibitors for maintenance therapy of erosive reflux esophagitis [PDF]

open access: bronze, 2001
Bonnie B. Dean   +4 more
openalex   +1 more source

South African Propolis: Anti‐Helicobacter pylori Activity, Chemistry, and Toxicity

open access: yesChemistry &Biodiversity, EarlyView.
ABSTRACT Propolis, a resin‐like substance produced by bees, has previously shown antimicrobial activity against the ulcer‐causing gut pathogen Helicobacter pylori. South African propolis, however, was yet to be investigated. This study aimed to investigate a comprehensive range of South African propolis for its antimicrobial activity against H.
Sarhana Dinat   +5 more
wiley   +1 more source

No Association Between Proton Pump Inhibitor Use and Risk of Alzheimer’s Disease

open access: yesAmerican Journal of Gastroenterology, 2017
H. Taipale   +5 more
semanticscholar   +1 more source

Proton pump inhibitors: a study of GPs' prescribing

open access: bronze, 2001
Miren I Jones   +4 more
openalex   +1 more source

Proton pump inhibitors and gastric acid secretion [PDF]

open access: green, 2001
M. Michael Wolfe   +2 more
openalex   +1 more source

Biodegradation of Juglone by Xanthomonas arboricola pv. juglandis, the Causal Agent of Walnut (Juglans regia L.) Bacterial Blight

open access: yesChemistry &Biodiversity, EarlyView.
ABSTRACT Xanthomonas arboricola pv. juglandis is the causal agent of walnut blight, a disease affecting Juglans regia L. cultivations by causing severe economic losses worldwide. The content of phenolic compounds in J. regia cultivars plays an important role in determining the resistance or susceptibility to the infection. In this study, the assessment
Marco Scortichini   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy